Trump administration announces MFN drug pricing deal with Pfizer
The Trump administration announced Pfizer has agreed to provide all of its medicines at Most Favored Nation (MFN) pricing in…
The Trump administration announced Pfizer has agreed to provide all of its medicines at Most Favored Nation (MFN) pricing in…
This January, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US,…
The Biden Administration had announced the price cuts that were negotiated by the Centers for Medicare and Medicaid Services (CMS)…
In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist…
The Biden Administration has released the highly anticipated list of 10 drugs selected for Medicare price negotiations under the US…
The Biden Administration has released the highly anticipated list of ten drugs selected for Medicare price negotiations under the Inflation…
This article is produced as part of GlobalData’s Price Intelligence (POLI) service, the world’s leading resource for global pharmaceutical pricing,…
Biosimilars for AbbVie’s (US) Humira (adalimumab) have finally launched in the US, bringing an end to Humira’s 20-year reign as…
Although the US midterm elections have not fully concluded, it is now known who has control of each chamber of…
For its latest high-profile review, the US Institute for Clinical and Economic Review (ICER) concluded that the three COVID-19 pills…